Literature DB >> 28221243

Effects of Glycyrrhizin on the Differentiation of Myeloid Cells of the Heart and Lungs in Lipopolysaccharide-Induced Septic Mice.

Eun-Hye Seo1, Ga-Yun Song, Byung Ok Kwak, Chung-Sik Oh, Seung Hyun Lee, Seong-Hyop Kim.   

Abstract

BACKGROUND: This study investigated the effects of glycyrrhizin (GR) on the ratio of myeloid-derived suppressor cells (MDSCs) to cluster of differentiation (CD)11b+Gr1 myeloid cells in the heart and lungs in lipopolysaccharide (LPS)-induced septic mice.
METHODS: Mice were divided into three groups: Control, LPS, and LPS+GR. After intraperitoneal injection of phosphate-buffered saline for the Control group, LPS for the LPS group, and a combination of LPS and GR for the LPS+GR group, fluorescence-activated cell sorting was utilized to evaluate cytokines and immune cells in the blood, heart, and lungs. Histopathologic analysis of Toll-like receptor (TLR)4 was also performed.
RESULTS: The cytokine amounts in the LPS and LPS+GR groups were significantly higher than in the Control group; however, that in the LPS+GR group was significant lower than in the LPS group. The ratio of MDSCs to CD11b+Gr1 myeloid cells in the LPS+GR group was significantly higher than in the LPS group but was significantly lower than in the Control group. The staining intensity of TLR4 showed the same pattern as that of cytokines in the heart and lungs. TLR4 staining was significantly lower in the LPS+GR group than in the LPS group but was higher than that in the Control group.
CONCLUSION: GR exhibited protective effects on the heart and lungs in LPS-induced septic mice. The effects were associated with an elevated ratio of MDSCs to CD11b+Gr1 myeloid cells and the inhibition of cytokine release and TLR4 expression after GR injection.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28221243     DOI: 10.1097/SHK.0000000000000850

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  4 in total

Review 1.  Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection?

Authors:  Harald Murck
Journal:  Front Immunol       Date:  2020-05-28       Impact factor: 7.561

2.  Adjunct Therapy With Glycyrrhiza Glabra Rapidly Improves Outcome in Depression-A Pilot Study to Support 11-Beta-Hydroxysteroid Dehydrogenase Type 2 Inhibition as a New Target.

Authors:  Harald Murck; Lisa Lehr; Johannes Hahn; Matthias C Braunisch; Daniela Jezova; Maxim Zavorotnyy
Journal:  Front Psychiatry       Date:  2020-12-10       Impact factor: 4.157

Review 3.  Licorice (Glycyrrhiza glabra) Extracts-Suitable Pharmacological Interventions for COVID-19? A Review.

Authors:  Joji Abraham; Singarayer Florentine
Journal:  Plants (Basel)       Date:  2021-11-26

4.  Single-Cell RNA-seq of Human Myeloid-Derived Suppressor Cells in Late Sepsis Reveals Multiple Subsets With Unique Transcriptional Responses: A Pilot Study.

Authors:  Dijoia B Darden; Rhonda Bacher; Maigan A Brusko; Parker Knight; Russell B Hawkins; Michael C Cox; Marvin L Dirain; Ricardo Ungaro; Dina C Nacionales; Jaimar C Rincon; Marie-Pierre L Gauthier; Michael Kladde; Azra Bihorac; Todd M Brusko; Frederick A Moore; Scott C Brakenridge; Alicia M Mohr; Lyle L Moldawer; Philip A Efron
Journal:  Shock       Date:  2021-05-01       Impact factor: 3.533

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.